Adverum Biotechnologies, Inc.

Historical 13F Holders

Symbol
ADVM
CUSIP
00773U108
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Every filing for 00773U108 since 12/18/2024, newest first.

Filer % of Class Filed
BML Investment Partners, L.P. 13D/A Amendment 3
0% 12/9/2025
Event 12/9/2025
BML Investment Partners, L.P. 13D/A Amendment 2
9.7% 12/5/2025
Event 12/4/2025
BML Investment Partners, L.P. 13D/A Amendment 1
15.6% 11/10/2025
Event 11/10/2025
BML Investment Partners, L.P. 13D
15.6% 5/20/2025
Event 5/19/2025
TCG Crossover GP II, LLC 13G/A Amendment 1
8.9% 5/15/2025
Event 3/31/2025
BML Investment Partners, L.P. 13G/A Amendment 5
13.8% 5/6/2025
Event 3/31/2025
BML Investment Partners, L.P. 13G/A Amendment 4
11.4% 2/13/2025
Event 12/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q3 1 507 k $2.30M
2025 Q2 1 507 k $1.09M
2025 Q1 1 507 k $2.21M
2024 Q4 1 507 k $2.37M
2024 Q3 1 507 k $3.56M
2024 Q2 2 2.52 M $17.3M
2024 Q1 3 3.58 M $50.7M
2023 Q4 62 73.8 M $55.6M
2023 Q3 64 65.3 M $97.9M
2023 Q2 59 65.7 M $104M
2023 Q1 56 70.5 M $50.6M
2022 Q4 61 57.6 M $33.4M
2022 Q3 80 58.5 M $55.6M
2022 Q2 79 58.2 M $70.0M
2022 Q1 95 63.6 M $86.4M
2021 Q4 102 66.1 M $119M
2021 Q3 114 70.0 M $155M
2021 Q2 124 79.2 M $280M
2021 Q1 135 95.1 M $938M
2020 Q4 157 96.1 M $1.04B
2020 Q3 162 95.2 M $980M
2020 Q2 144 80.9 M $1.69B
2020 Q1 128 80.8 M $790M
2019 Q4 118 60.9 M $702M
2019 Q3 104 49.0 M $267M
2019 Q2 95 46.4 M $549M
2019 Q1 84 39.7 M $208M
2018 Q4 87 39.1 M $123M
2018 Q3 104 35.3 M $274M
2018 Q2 102 37.0 M $196M
2018 Q1 97 34.9 M $202M
2017 Q4 65 19.2 M $67.3M
2017 Q3 58 13.6 M $49.5M
2017 Q2 63 13.0 M $32.5M
2017 Q1 75 13.9 M $37.4M
2016 Q4 83 15.2 M $44.0M
2016 Q3 78 15.3 M $62.7M
2016 Q2 77 15.8 M $49.8M
2016 Q1 3 226 k $1.17M